|
BCL9 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.172690E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.381680E-04 |
| Normal-vs-Stage2 |
1.999380E-01 |
| Normal-vs-Stage3 |
2.396300E-03 |
| Normal-vs-Stage4 |
6.750900E-04 |
| Stage1-vs-Stage2 |
1.527440E-01 |
| Stage1-vs-Stage3 |
6.567600E-01 |
| Stage1-vs-Stage4 |
6.571000E-01 |
| Stage2-vs-Stage3 |
2.799200E-01 |
| Stage2-vs-Stage4 |
1.141150E-01 |
| Stage3-vs-Stage4 |
4.313600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.96099999999677E-05 |
| Normal-vs-AfricanAmerican |
6.550800E-04 |
| Normal-vs-Asian |
3.516000E-03 |
| Caucasian-vs-AfricanAmerican |
3.588800E-01 |
| Caucasian-vs-Asian |
9.048600E-01 |
| AfricanAmerican-vs-Asian |
3.484800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.988090E-02 |
| Normal-vs-Female |
3.69789999999925E-05 |
| Male-vs-Female |
2.616100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.96920000000201E-05 |
| Normal-vs-Age(41-60Yrs) |
3.613300E-04 |
| Normal-vs-Age(61-80Yrs) |
1.699710E-02 |
| Normal-vs-Age(81-100Yrs) |
4.503000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.148800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.068800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.464300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.045000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.021020E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.555000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.631180E-01 |
| Classical-VS-Follicular |
1.18639986723679E-10 |
| Classical-VS-Other |
1.459790E-01 |
| Classical-VS-Normal |
9.37299999836938E-08 |
| Tall-VS-Follicular |
7.362400E-03 |
| Tall-VS-Other |
4.315200E-01 |
| Tall-VS-Normal |
2.316000E-02 |
| Follicular-VS-Other |
4.810000E-01 |
| Follicular-VS-Normal |
5.245400E-01 |
| Other-VS-Normal |
6.241400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.261840E-02 |
| Normal-vs-N1 |
4.880300E-03 |
| N0-vs-N1 |
3.842000E-01 |
|
|
